Updated Jul 16, 2026
Coyne Terrance P. has filed 3 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $24.78M.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-28 | RPRX | Royalty Pharma plc | S — Open-market sale | 64.4K | $53.98 | $3.48M |
| 2026-05-08 | RPRX | Royalty Pharma plc | A — Grant or award | 24.3K | $0.00 | |
| 2026-04-30 | RPRX | Royalty Pharma plc | S — Open-market sale | 1.9K | $49.78 | $93K |
| 2026-04-30 | RPRX | Royalty Pharma plc | S — Open-market sale | 32.9K | $49.78 | $1.64M |
| 2026-04-02 | RPRX | Royalty Pharma plc | S — Open-market sale [10b5-1] | 32.9K | $48.33 | $1.59M |
| 2026-04-02 | RPRX | Royalty Pharma plc | S — Open-market sale [10b5-1] | 1.9K | $48.33 | $91K |
| 2026-03-25 | RPRX | Royalty Pharma plc | S — Open-market sale [10b5-1] | 1.9K | $45.53 | $85K |
| 2026-03-25 | RPRX | Royalty Pharma plc | S — Open-market sale [10b5-1] | 32.9K | $45.53 | $1.50M |
| 2026-03-04 | RPRX | Royalty Pharma plc | S — Open-market sale [10b5-1] | 583 | $47.01 | $27K |
| 2026-03-04 | RPRX | Royalty Pharma plc | S — Open-market sale [10b5-1] | 1.3K | $46.67 | $60K |
| 2026-03-04 | RPRX | Royalty Pharma plc | S — Open-market sale [10b5-1] | 10.4K | $47.01 | $490K |
| 2026-03-04 | RPRX | Royalty Pharma plc | S — Open-market sale [10b5-1] | 22.5K | $46.67 | $1.05M |
| 2026-02-25 | RPRX | Royalty Pharma plc | S — Open-market sale [10b5-1] | 1.9K | $45.32 | $85K |
| 2026-02-25 | RPRX | Royalty Pharma plc | S — Open-market sale [10b5-1] | 32.9K | $45.32 | $1.49M |
| 2026-02-13 | RPRX | Royalty Pharma plc | A — Grant or award | 26.6K | $0.00 | |
| 2026-02-04 | RPRX | Royalty Pharma plc | S — Open-market sale [10b5-1] | 1.1K | $43.29 | $47K |
| 2026-02-04 | RPRX | Royalty Pharma plc | S — Open-market sale [10b5-1] | 6.2K | $42.84 | $265K |
| 2026-02-04 | RPRX | Royalty Pharma plc | S — Open-market sale [10b5-1] | 5.8K | $42.08 | $246K |
| 2026-02-04 | RPRX | Royalty Pharma plc | S — Open-market sale [10b5-1] | 19.1K | $43.29 | $826K |
| 2026-02-04 | RPRX | Royalty Pharma plc | S — Open-market sale [10b5-1] | 108.8K | $42.84 | $4.66M |
Coyne Terrance P. is a corporate insider — currently tracked as EVP & CFO of Royalty Pharma plc (RPRX). InsiderAlpha tracks every SEC Form 4 filing in real time.
3 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 21 open-market sales ($24.78M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Coyne Terrance P. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.